LUCIRE
www.lucire.com
Living section
October 2003

Peptide Promises
M.K. Johnson

“Perhaps the most commercially viable Botox® alternative, acetyl-hexapeptide (trade name Argeriline), developed by Spanish company Centerchem is showing promise as a less toxic, much less invasive alternative to the controversial injections. Argeriline works through a unique mechanism which relaxes facial tension leading to a reduction in superficial facial lines and wrinkles with regular use. Argeriline has been shown to moderate excessive catecholamine (neurotransmitters that are believed to cause the formation of the expressions leading to lines) release results showed reduced wrinkle depth up to 30% upon 30 days’ treatment optimum concentration is around the 10% mark.”